Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
about
Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.An overview of the extra-lipid effects of rosuvastatin.The role of statin drugs in the management of the peripheral vascular patient.Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.
P2860
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@ast
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@en
type
label
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@ast
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@en
prefLabel
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@ast
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@en
P2860
P1476
Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
@en
P2093
Keith C Ferdinand
P2860
P304
P356
10.1517/14656566.6.11.1897
P407
P577
2005-09-01T00:00:00Z